Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors

Abstract

Most T lymphocytes, including regulatory T cells (Treg cells), differentiate in the thymus. The age-dependent involution of this organ leads to decreasing production of T cells. Here we found that the output of new Treg cells from the thymus decreased substantially more than that of conventional T cells. Peripheral mouse and human Treg cells recirculated back to the thymus, where they constituted a large proportion of the pool of Treg cells and displayed an activated and differentiated phenotype. In the thymus, the recirculating cells exerted their regulatory function by inhibiting interleukin 2 (IL-2)-dependent de novo differentiation of Treg cells. Thus, Treg cell development is controlled by a negative feedback loop in which mature progeny cells return to the thymus and restrain development of precursors of Treg cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Thymic production of Treg cells decreases substantially with age.
Figure 2: Peripheral Treg cells are able to recirculate to the thymus.
Figure 3: Recirculating Treg cells in the thymus have an activated and differentiated phenotype.
Figure 4: Mature peripheral Treg cells that reenter the thymus inhibit the differentiation of Treg cells.
Figure 5: Activated and differentiated peripheral Treg cells also recirculate to the thymus in humans.

Similar content being viewed by others

Accession codes

Primary accessions

Sequence Read Archive

References

  1. Sakaguchi, S., Miyara, M., Costantino, C.M. & Hafler, D.A. FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 10, 490–500 (2010).

    CAS  PubMed  Google Scholar 

  2. Josefowicz, S.Z., Lu, L.F. & Rudensky, A.Y. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30, 531–564 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Romagnoli, P., Hudrisier, D. & van Meerwijk, J.P.M. Preferential recognition of self-antigens despite normal thymic deletion of CD4+CD25+ regulatory T cells. J. Immunol. 168, 1644–1648 (2002).

    CAS  PubMed  Google Scholar 

  4. Hsieh, C.S. et al. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 21, 267–277 (2004).

    CAS  PubMed  Google Scholar 

  5. Chidgey, A., Dudakov, J., Seach, N. & Boyd, R. Impact of niche aging on thymic regeneration and immune reconstitution. Semin. Immunol. 19, 331–340 (2007).

    CAS  PubMed  Google Scholar 

  6. Nikolich-Žugich, J. Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nat. Rev. Immunol. 8, 512–522 (2008).

    PubMed  PubMed Central  Google Scholar 

  7. Yu, W. et al. Continued RAG expression in late stages of B cell development and no apparent re-induction after immunization. Nature 400, 682–687 (1999).

    CAS  PubMed  Google Scholar 

  8. Borgulya, P., Kishi, H., Uematsu, Y. & von Boehmer, H. Exclusion and inclusion of alpha and beta T cell receptor alleles. Cell 69, 529–537 (1992).

    CAS  PubMed  Google Scholar 

  9. McCaughtry, T.M., Wilken, M.S. & Hogquist, K.A. Thymic emigration revisited. J. Exp. Med. 204, 2513–2520 (2007).

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Liston, A. et al. Differentiation of regulatory Foxp3+ T cells in the thymic cortex. Proc. Natl. Acad. Sci. USA 105, 11903–11908 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Almeida, A.R. et al. Quorum-sensing in CD4+ T cell homeostasis: a hypothesis and a model. Front Immunol. 3, 125 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Liston, A. & Gray, D.H. Homeostatic control of regulatory T cell diversity. Nat. Rev. Immunol. 14, 154–165 (2014).

    CAS  PubMed  Google Scholar 

  13. Cuss, S.M. & Green, E.A. Abrogation of CD40–CD154 signaling impedes the homeostasis of thymic resident regulatory T cells by altering the levels of IL-2, but does not affect regulatory T cell development. J. Immunol. 189, 1717–1725 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Yang, E., Zou, T., Leichner, T.M., Zhang, S.L. & Kambayashi, T. Both retention and recirculation contribute to long-lived regulatory T-cell accumulation in the thymus. Eur. J. Immunol. 44, 2712–2720 (2014).

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Attridge, K. & Walker, L.S. Homeostasis and function of regulatory T cells (Tregs) in vivo: lessons from TCR-transgenic Tregs. Immunol. Rev. 259, 23–39 (2014).

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Fink, P.J., Swan, K., Turk, G., Moore, M.W. & Carbone, F.R. Both intrathymic and peripheral selection modulate the differential expression of Vβ5 among CD4+ and CD8+ T cells. J. Exp. Med. 176, 1733–1738 (1992).

    CAS  PubMed  Google Scholar 

  17. McMahan, C.J. & Fink, P.J. RAG reexpression and DNA recombination at T cell receptor loci in peripheral CD4+ T cells. Immunity 9, 637–647 (1998).

    CAS  PubMed  Google Scholar 

  18. Papiernik, M., de Moraes, M.L., Pontoux, C., Vasseur, F. & Penit, C. Regulatory CD4 T cells: expression of IL-2Rα chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol. 10, 371–378 (1998).

    CAS  PubMed  Google Scholar 

  19. Zhan, Y., Corbett, A.J., Brady, J.L., Sutherland, R.M. & Lew, A.M. Delayed rejection of fetal pig pancreas in CD4 cell deficient mice was correlated with residual helper activity. Xenotransplantation 7, 267–274 (2000).

    CAS  PubMed  Google Scholar 

  20. Agus, D.B., Surh, C.D. & Sprent, J. Re-entry of T cells to the adult thymus is restricted to activated T cells. J. Exp. Med. 173, 1039–1046 (1991).

    CAS  PubMed  Google Scholar 

  21. Leng, Q., Nie, Y., Zou, Y. & Chen, J. Elevated CXCL12 expression in the bone marrow of NOD mice is associated with altered T cell and stem cell trafficking and diabetes development. BMC Immunol. 9, 51 (2008).

    PubMed  PubMed Central  Google Scholar 

  22. Bajoghli, B. et al. Evolution of genetic networks underlying the emergence of thymopoiesis in vertebrates. Cell 138, 186–197 (2009).

    CAS  PubMed  Google Scholar 

  23. Joller, N. et al. Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity 40, 569–581 (2014).

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Lee, H.M. & Hsieh, C.S. Rare development of Foxp3+ thymocytes in the CD4+CD8+ subset. J. Immunol. 183, 2261–2266 (2009).

    CAS  PubMed  Google Scholar 

  25. Pandiyan, P., Zheng, L., Ishihara, S., Reed, J. & Lenardo, M.J. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat. Immunol. 8, 1353–1362 (2007).

    CAS  PubMed  Google Scholar 

  26. Cheng, G., Yu, A. & Malek, T.R. T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells. Immunol. Rev. 241, 63–76 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Lio, C.W. & Hsieh, C.S. A two-step process for thymic regulatory T cell development. Immunity 28, 100–111 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Kimmig, S. et al. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J. Exp. Med. 195, 789–794 (2002).

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Miyara, M. et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30, 899–911 (2009).

    CAS  PubMed  Google Scholar 

  30. Dominguez-Villar, M., Baecher-Allan, C.M. & Hafler, D.A. Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease. Nat. Med. 17, 673–675 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Duhen, T., Duhen, R., Lanzavecchia, A., Sallusto, F. & Campbell, D.J. Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells. Blood 119, 4430–4440 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Bosco, N., Agenes, F., Rolink, A.G. & Ceredig, R. Peripheral T cell lymphopenia and concomitant enrichment in naturally arising regulatory T cells: the case of the pre-Tα gene-deleted mouse. J. Immunol. 177, 5014–5023 (2006).

    CAS  PubMed  Google Scholar 

  33. Romagnoli, P. et al. The thymic niche does not limit development of the naturally diverse population of mouse regulatory T lymphocytes. J. Immunol. 189, 3831–3837 (2012).

    CAS  PubMed  Google Scholar 

  34. Smigiel, K.S. et al. CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets. J. Exp. Med. 211, 121–136 (2014).

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Tai, X. et al. Foxp3 transcription factor is proapoptotic and lethal to developing regulatory T cells unless counterbalanced by cytokine survival signals. Immunity 38, 1116–1128 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Yasunaga, J. et al. Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state. Blood 97, 3177–3183 (2001).

    CAS  Google Scholar 

  37. Pilarski, L.M., Mant, M.J., Ruether, B.A. & Belch, A. Severe deficiency of B lymphocytes in peripheral blood from multiple myeloma patients. J. Clin. Invest. 74, 1301–1306 (1984).

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Fisson, S. et al. Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J. Exp. Med. 198, 737–746 (2003).

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Boursalian, T.E., Golob, J., Soper, D.M., Cooper, C.J. & Fink, P.J. Continued maturation of thymic emigrants in the periphery. Nat. Immunol. 5, 418–425 (2004).

    CAS  PubMed  Google Scholar 

  40. Trapnell, C. et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7, 562–578 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Pavlidis, P. & Noble, W.S. Matrix2png: a utility for visualizing matrix data. Bioinformatics 19, 295–296 (2003).

    CAS  PubMed  Google Scholar 

  43. Cabaniols, J.P., Fazilleau, N., Casrouge, A., Kourilsky, P. & Kanellopoulos, J.M. Most α/β T cell receptor diversity is due to terminal deoxynucleotidyl transferase. J. Exp. Med. 194, 1385–1390 (2001).

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Fazilleau, N. et al. T cell repertoire diversity is required for relapses in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J. Immunol. 178, 4865–4875 (2007).

    CAS  PubMed  Google Scholar 

  45. Arden, B., Clark, S.P., Kabelitz, D. & Mak, T.W. Mouse T-cell receptor variable gene segment families. Immunogenetics 42, 501–530 (1995).

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank A. Lew (Walter & Eliza Hall Institute of Medical Research) and A. Egle (Salzburg Cancer Research Institute) for GK-transgenic mice; P. Fink (University of Washington, Seattle) for B6 Rag-GFP mice; A. Rudensky (Memorial Sloan-Kettering Cancer Center) and A. Liston (University of Leuven) for Foxp3-Thy-1.1 mice; S. Guerder and J.-C. Guéry for critical reading of the manuscript; F. Auriol and A. Garnier for help in obtaining human thymuses; F.-E. L'Faqihi-Olive and V. Duplan-Eche for technical assistance at the flow-cytometry facility; S. Allart and A. Canivet for technical assistance at the cellular imaging facility of Inserm U1043, Toulouse; the personnel of the Inserm US006 ANEXPLO/CREFRE animal facility for expert animal care; and the GeT-PlaGe and GenoToul bioinformatics platforms Toulouse Midi-Pyrénées for sequencing, computing and storage resources. Supported by the Fondation pour la Recherche Médicale (O.P.J. and J.P.M.v.M.), the IdEx Toulouse (E.A.R. and P.R.), the Région Midi Pyrénées (O.P.J. and J.P.M.v.M.) and the Agence Nationale pour la Recherche (O.P.J.).

Author information

Authors and Affiliations

Authors

Contributions

N.T., J.D. and V.A. performed experiments, analyzed data and contributed to writing the manuscript; M.G. and B.B. performed experiments and analyzed data; C.P. performed experiments; B.L. provided clinical samples; N.F., O.P.J. and E.A.R. designed experiments and analyzed data; J.P.M.v.M. and P.R. designed experiments, analyzed the data and wrote the manuscript; and all authors critically reviewed the manuscript.

Corresponding authors

Correspondence to Joost P M van Meerwijk or Paola Romagnoli.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Integrated supplementary information

Supplementary Figure 1 Gating strategy used to calculate the proportions of GFP and GFP+ Tconv cells and Treg cells in thymus and spleen from Rag‑GFPFoxp3-Thy-1.1 mice.

(a) Thymocytes and (b) splenocytes were stained with fluorescent antibodies against the indicated markers and analyzed by flow cytometry. CD4 and CD8 expression on electronically gated live cells (FSC/SSC gate, not shown) is depicted (upper left). CD4+CD8 (CD4SP and CD4+) cells were electronically gated as depicted and Thy1.1 expression was analyzed (upper right). GFP-expression was then analyzed on further gated Thy1.1 Tconv cells (lower left) and Thy1.1+ Treg cells (lower right). Numbers indicate percentages of cells within the indicated electronic gates.

Supplementary Figure 2 Longitudinal analysis of the proportion of splenic Treg cells.

Splenocytes from Rag‑GFPFoxp3-Thy-1.1 mice of indicated ages were stained with fluorescent antibodies against CD4, CD8, and Thy1.1 and analyzed by flow cytometry. Live cells were gated electronically (FSC/SSC gate, not shown) and the proportion of Thy1.1+ Treg cells among CD4+CD8 splenocytes was calculated. Values for all the individual mice analyzed are shown.

Source data

Supplementary Figure 3 Analysis of the TCR Vβ repertoire of GFP+ and GFP Treg cells in the thymus and spleen from Rag-GFPFoxp3-Thy-1.1 mice.

(a) Thymocytes and splenocytes were analyzed as in supplementary Fig. 1 but with the addition of antibodies to the indicated TCR Vβ segments. Expression of Vβ5, Vβ6, and Vβ11 on the indicated, electronically gated CD4+CD8 Thy1.1+ Treg populations is shown. Numbers indicate percentages of cells within indicated electronic gates. Fig. 2c shows the quantitative analysis of thus performed experiments. (b) Percentages of Vβ5-expressing cells in the indicated populations (left). Percentage of peripheral deletion of Vβ5-expressing cells calculated from the data in the left panel (right). The data shown are means ± SD, n=9 from three independent experiments. *p<0.01; Wilcoxon matched pairs signed rank test. (c) Newly developing GFP+ and recirculating GFP thymic CD4+CD8Thy-1.1+ Treg cells were analyzed by immunoscope. The peaks within each distribution represent sequences that differ by three bases (one amino acid). The Gaussian-like Vβ-Cβ distribution profiles obtained indicate that the populations of Vβ6- or Vβ11-expressing Treg cells are polyclonal (Vβ5 plots are shown as a control). Shown are representative results from three experiments performed. (d) The percentages of cells expressing the indicated control TCR Vβ segments among the electronically gated indicated CD4+CD8 Thy1.1+ Treg cell populations were analyzed by flow cytometry. The data shown are means ± SD, n=9 from three independent experiments. NS, not significant as determined by the Wilcoxon matched pairs signed rank test.

Source data

Supplementary Figure 4 Peripheral depletion of CD4+ T cells and reduced proportions of thymic GFP Treg cells in GK-transgenic Rag-GFPFoxp3-Thy-1.1 mice.

(a) Flow cytometry of CD4 versus CD8 expression on electronically gated TCRhi splenocytes from control (“Wt”) and GK-transgenic Rag-Gfp/Foxp3-Thy1.1 mice. Numbers indicate percentages of cells within indicated gates. A representative experiment out of three performed is shown. (b) Flow cytometry of CD4 versus CD8 expression by thymocytes from indicated mice. The numbers above the boxed populations indicate the percentages of mature CD4+CD8 cells among total thymocytes. A representative experiment out of three performed is shown. (c) Analysis of Thy-1.1 expression by electronically gated CD4+CD8 thymocytes from indicated mice. Numbers indicate percentage of cells within indicated gates. Quantitative analysis of thus performed experiments is shown in Fig. 2d, left. (d) GFP expression on electronically gated CD4+CD8Thy-1.1+ thymic Treg cells. Numbers indicate percentage of cells within indicated gates. Quantitative analysis of thus performed experiments is shown in Fig. 2d, right. (e) Cell cycle analysis of GFP+ and GFP thymic Treg cells in non-transgenic and GK-transgenic mice. Cell cycle status was analyzed by flow-cytometry. Percentages of cycling cells (S, G2, and M phase) for all studied populations are indicated (means ± SD, n=4 control and 4 GK mice). NS, not significant, Mann-Whitney test.

Source data

Supplementary Figure 5 Peripheral Treg cells recirculate to the thymus.

(a) In vitro expanded and cell trace violet (CTV)-labeled Treg cells (8–10×106 cells/mouse) were injected i.v. into wt mice. One day later, the thymus of the adoptive host was analyzed by flow-cytometry using antibodies to CD4, CD8, CD25, and Foxp3. In the left plot, expression of Foxp3 and CD25 on electronically gated CD4+CD8 thymocytes is shown. The right plot shows CTV-marked cells in the Treg population, electronically gated as shown. The number indicates the percentage of cells within the indicated gate. Quantitative analysis of thus performed analyses is shown in Fig. 2e. One day after their i.v. injection into wild-type mice, in vitro activated Tconv cells (b) and in vitro generated iTreg cells (c) were found in the spleen and thymus of host mice. Shown are the percentages of indicated cells among Tconv (b) and Treg (c) cells in spleen and thymus (individual mice are shown, horizontal lines indicate mean values, 3 independent experiments, *p<0.01; Wilcoxon matched pairs signed rank test). (d) CXCR4 versus GFP expression by electronically gated CD4+CD8Foxp3+ thymic Treg cells from Rag-GFP/Foxp3-Thy-1.1 mice. A representative experiment out of three performed is shown. (e) Percentages of Foxp3+ Treg cells among electronically gated CD4+CD8TCRhiH-2Kb-negative cells from fetal thymus cultures performed in the absence or presence of added in vitro activated H-2Kb-positive Tconv cells. The data from two independent experiments are shown. NS, not significant; Mann Whitney test.

Source data

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–5 and Supplementary Tables 1 and 2 (PDF 429 kb)

Source data

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Thiault, N., Darrigues, J., Adoue, V. et al. Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors. Nat Immunol 16, 628–634 (2015). https://doi.org/10.1038/ni.3150

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ni.3150

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing